US$ 26.19
glp 1 receptor agonists canada GLP-1 Agonist Market Size & Analysis, 2026-2033 Real-World Evidence for GLP-1 Receptor
Description
10.1016/j.ijcard.2016.06.028 39

These data indicate that d-allulose ameliorates basal hyperglycemia and impaired glucose tolerance (IGT) in HFD-fed mice via GLP-1R signaling

Side effects like nausea, vomiting, diarrhea, or constipation are common early on but often improve with proper management
Changes relative to baseline lean mass were similar between the groups, and meta-regression analysis indicated that reductions in total body weight were significantly associated with fat mass loss but not with lean mass

These results point to heterogeneity between liraglutide and exenatide
